Translating cutting-edge science into therapeutic breakthroughs. Strategic consulting across immunology, oncology, and rare diseases for biotech and pharmaceutical companies.
Deep scientific knowledge and hands-on research experience across three core therapeutic domains.
Mechanistic expertise in immune modulation, autoimmune pathways, and inflammatory disease biology for therapeutic target identification and validation.
Explore Immunology →Comprehensive cancer biology expertise covering tumor microenvironment, checkpoint biology, and novel immuno-oncology targets across multiple tumor types.
Explore Oncology →Strategic expertise in rare disease drug development including orphan drug designation, biomarker strategy, and patient-centric development approaches.
Explore Rare Diseases →End-to-end drug discovery support from target identification through IND-enabling studies.
Full-spectrum drug discovery support from target identification and validation through hit discovery, lead optimization, and candidate selection strategies.
Learn more →Comprehensive in vitro pharmacology study design, execution oversight, and data interpretation for mechanism of action and potency characterization.
Learn more →Strategic design and oversight of in vivo efficacy and safety studies across multiple disease models with translational biomarker integration.
Learn more →Bridging preclinical findings to clinical applications through biomarker identification, patient stratification strategies, and translational frameworks.
Learn more →Expert guidance at every stage of the drug discovery and development continuum.
Let's discuss how deep scientific expertise and strategic consulting can accelerate your drug discovery program.